182 related articles for article (PubMed ID: 16352933)
1. [Clinical study of ambulatory patient cancer chemotherapy for advanced colorectal cancer].
Toyokawa A; Tsujimura T; Hamabe Y; Sato S; Mukubou H; Wakahara T; Kaji M; Tsukamoto T; Wakita K; Onishi N; Ishida T; Watanabe A; Fujiwara H; Mukai H
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2087-90. PubMed ID: 16352933
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study of ambulatory cancer chemotherapy for advanced colorectal cancer].
Takahashi N; Kunii Y; Ota K
Gan To Kagaku Ryoho; 1995 Dec; 22 Suppl 4():447-52. PubMed ID: 8849291
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of tegafur/uracil plus oral leucovorin therapy for advanced or recurrent colorectal cancer].
Kabashima A; Sakaguchi Y; Okita K; Yamamura S; Ojima Y; Nishizaki T; Tashiro H; Matsuzaka T
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1935-8. PubMed ID: 16282730
[TBL] [Abstract][Full Text] [Related]
4. [Retrospective analysis of tegafur/uracil (UFT) plus oral leucovorin (LV) regimen in patients with advanced colorectal cancer].
Sato Y; Inaba Y; Yamaura H; Shimamoto H; Nishiofuku H; Oyama T; Kanemitsu Y; Sawaki A; Arai Y; Muro K
Gan To Kagaku Ryoho; 2006 Jul; 33(7):887-90. PubMed ID: 16835473
[TBL] [Abstract][Full Text] [Related]
5. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of UFT plus oral leucovorin in advanced colorectal cancer: a multicenter study.
Thongprasert S; Maoleekoonpairoj S; Laohavinij S; Thavichaigarn P
J Med Assoc Thai; 2000 Jun; 83(6):676-80. PubMed ID: 10932496
[TBL] [Abstract][Full Text] [Related]
7. Oral regimen consisting of UFT/UZEL for elderly patients with colorectal cancer.
Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Yamaki S; Asao T; Kuwano H
Hepatogastroenterology; 2006; 53(68):209-12. PubMed ID: 16608026
[TBL] [Abstract][Full Text] [Related]
8. Postsurgical sequential methotrexate/5-FU and leucovorin on outpatient basis for advanced colorectal carcinoma.
Tokunaga Y; Kitaoka A; Yagi T; Tokuka A; Ohsumi K
Hepatogastroenterology; 2001; 48(37):128-32. PubMed ID: 11268947
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL
J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of uracil/tegafur (UFT) plus oral Leucovorin (LV) therapy for colorectal cancer in elderly patients].
Mizushima T; Mizuno H; Ito T; Hoki M; Souma Y; Iwamoto T; Ozawa H; Kanou T; Nakamori Y; Iwase K
Gan To Kagaku Ryoho; 2006 Jul; 33(7):941-4. PubMed ID: 16835484
[TBL] [Abstract][Full Text] [Related]
11. Retrospective study of S-1 versus tegafur/uracil and oral leucovorin in patients with metastatic colorectal cancer.
Shibahara K; Yamamoto M; Kakeji Y; Sakata H; Maehara Y
Anticancer Res; 2008; 28(3B):1779-83. PubMed ID: 18630459
[TBL] [Abstract][Full Text] [Related]
12. Tegafur-uracil (UFT) plus folinic acid in advanced rectal cancer.
Sanchiz F; Milla A
Jpn J Clin Oncol; 1994 Dec; 24(6):322-6. PubMed ID: 7830337
[TBL] [Abstract][Full Text] [Related]
13. [Home chemotherapy by concomitant UFT + Leucovorin (po.) in postoperative colorectal cancer patients assessed with Dukes D and curability C colorectal cancer].
Sakuyama T; Yokoyama M; Ogawa M; Takao Y; Sato K; Kawahara H; Anazawa S; Yamazaki Y; Hirai K
Gan To Kagaku Ryoho; 2004 May; 31(5):771-5. PubMed ID: 15170991
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299.
Hochster HS; Luo W; Popa EC; Lyman BT; Mulcahy M; Beatty PA; Benson AB
J Clin Oncol; 2007 Dec; 25(34):5397-402. PubMed ID: 18048821
[TBL] [Abstract][Full Text] [Related]
15. [Optimal dosage of UFT + MMC combination chemotherapy for advanced colorectal cancer--phase I/II study of combination chemotherapy of MMC with 2-week intervals and intermittent UFT administration--Study Group of UFTM Therapy for Advanced Colorectal Cancer].
Ikeda E; Kodaira S; Teramoto T; Okuda M; Takahashi T; Kato T; Yamamoto Y; Isomoto H
Gan To Kagaku Ryoho; 1996 Sep; 23(10):1291-8. PubMed ID: 8831741
[TBL] [Abstract][Full Text] [Related]
16. [Phase I study of orally administered UFT plus l-leucovorin].
Horikoshi N; Aiba K; Kanamaru R; Hasegawa K; Takeda S; Taguchi T; Niitani H; Furue H; Kurihara M; Ogawa M; Abe T
Gan To Kagaku Ryoho; 1998 Mar; 25(4):531-9. PubMed ID: 9530359
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of UFT plus leucovorin in advanced colorectal cancer: a double modulation proposal.
González Barón M; Feliu J; Ordoñez A; Colmenarejo A; Espinosa E; Zamora P; de la Gandara I; Jalon JI
Anticancer Res; 1993; 13(3):759-62. PubMed ID: 8317909
[TBL] [Abstract][Full Text] [Related]
18. [Feasibility of weekday-on/weekend-off oral UFT/Leucovorin schedule as postoperative adjuvant chemotherapy for colorectal cancer].
Sadahiro S; Suzuki T; Maeda Y; Makuuchi H; Murayama C
Gan To Kagaku Ryoho; 2006 Mar; 33(3):333-6. PubMed ID: 16531713
[TBL] [Abstract][Full Text] [Related]
19. [Combination chemotherapy with tegafur-uracil (UFT) and cisplatin (CDDP) for advanced gastric cancer. UFTP Study Group].
Sato A; Hasegawa K; Kurihara M; Takahashi M; Akazawa S; Fukuyama Y; Koizumi W; Hayakawa M; Sasai T; Kimura K
Gan To Kagaku Ryoho; 1995 Sep; 22(10):1355-62. PubMed ID: 7668870
[TBL] [Abstract][Full Text] [Related]
20. A multiple-center phase II study of biweekly oxaliplatin and tegafur-uracil/leucovorin for chemonaive patients with advanced gastric cancer.
Chen JS; Rau KM; Chen YY; Huang JS; Yang TS; Lin YC; Liau CT; Lee KD; Su YC; Kao RH
Cancer Chemother Pharmacol; 2009 Apr; 63(5):819-25. PubMed ID: 18663448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
